Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
177M
-
Number of holders
-
65
-
Total 13F shares, excl. options
-
12M
-
Shares change
-
-2.12M
-
Total reported value, excl. options
-
$53.6M
-
Value change
-
-$12M
-
Put/Call ratio
-
1.3
-
Number of buys
-
24
-
Number of sells
-
-38
-
Price
-
$4.45
Significant Holders of OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) as of Q4 2017
87 filings reported holding OCUL - OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share as of Q4 2017.
OCULAR THERAPEUTIX, INC - Common Stock, $0.0001 par value per share (OCUL) has 65 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12M shares
of 177M outstanding shares and own 6.8% of the company stock.
Largest 10 shareholders include Versant Venture Management, LLC (2.22M shares), JENNISON ASSOCIATES LLC (1.99M shares), SV Health Investors, LLC (1.61M shares), WELLINGTON MANAGEMENT GROUP LLP (1.25M shares), FMR LLC (1.16M shares), Vanguard Group Inc (1.07M shares), STATE STREET CORP (352K shares), NORTHERN TRUST CORP (262K shares), MORGAN STANLEY (259K shares), and DELTEC ASSET MANAGEMENT LLC (214K shares).
This table shows the top 65 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.